![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0016.png)
15
Diretrizes AMB
11.
Carnahan KD, Arner M, Hägglund G. Association between gross motor function (GMFCS) and
manual ability (MACS) in children with cerebral palsy. A population-based study of 359 children.
BMC Musculoskelet Disord 2007; 8:50. PMID: 17584944.
12.
Dalvand H, Dehghan L, Hadian MR, Feizy A, Hosseini SA. Relationship between gross motor
and intellectual function in children with cerebral palsy: a cross-sectional study. Arch Phys Med
Rehabil 2012; 93: 480-4. PMID: 22265344.
13.
Guarany FC, Picon PD, Guarany NR, dos Santos AC, Chiella BP, Barone CR, et al. A double-
blind, randomised, crossover trial of two botulinum toxin type a in patients with spasticity. PLoS
One 2013; 8: e56479. PMID: 23468866.
14.
Himmelmann K, Beckung E, Hagberg G, Uvebrant P. Gross and fine motor function and
accompanying impairments in cerebral palsy. Dev Med Child Neurol 2006; 48: 417-23. PMID:
16700930.
15.
Kanovský P, Bares M, Severa S, Richardson A; Dysport Paediatric Limb Spasticity Study Group.
Long-term efficacy and tolerability of 4-monthly versus yearly botulinum toxin type A treatment
for lower-limb spasticity in children with cerebral palsy. Dev Med Child Neurol 2009; 51: 436-45.
PMID: 19563586.